Pneuma Therapeutics Partners with MED Alliance to Expand xchange™ Distribution

SAN DIEGO, CA, UNITED STATES, October 8, 2026 /CourierPR/ -- Pneuma Therapeutics, an innovative medical device company based in San Diego, has entered into a strategic partnership with MED Alliance Group to expand the commercial reach of its xchange™ Anesthesia Airway Management Device. This collaboration aims to enhance access to xchange™ for anesthesia providers across hospitals and ambulatory surgery centers, addressing critical challenges in maintaining airway patency and adequate oxygenation during anesthesia and procedural sedation.

The xchange™ device, developed by Pneuma Therapeutics, offers a noninvasive, single-use solution for delivering positive airway pressure through a nasal interface. It features adjustable positive airway pressure, real-time pressure visualization, and the capability to monitor end-tidal carbon dioxide, providing clinicians with greater control and visibility over airway management. Unlike conventional oxygen delivery systems, xchange™ is designed to support spontaneous ventilation, making it a practical alternative for perioperative airway management.

The partnership leverages MED Alliance's established distribution network and relationships with healthcare providers, enabling the introduction of xchange™ to hospitals, ambulatory surgery centers, and anesthesia professionals across its territories. The device's key features include noninvasive nasal CPAP, adjustable positive airway pressure up to 20 cmH₂O, real-time pressure visualization, etCO₂ monitoring capability, and a single-use, universal design that simplifies inventory management and clinical workflow.

Pneuma Therapeutics and MED Alliance's collaboration reflects a shared commitment to bringing innovative medical technologies to the healthcare professionals and patients who can benefit from them. By integrating into existing anesthesia workflows, xchange™ offers a differentiated approach to perioperative airway management, supporting the evolving needs of anesthesia providers in prioritizing patient safety, procedural efficiency, and cost-effective care.

The xchange™ device is designed to support airway management during anesthesia and procedural sedation, addressing challenges faced by patients with obesity, obstructive sleep apnea, and other risk factors for airway obstruction. Its ability to deliver positive airway pressure through an integrated adjustable pressure-limiting valve and provide real-time pressure visualization through an integrated manometer enhances the clinical functionality and ease of use for anesthesia professionals.

This strategic partnership is expected to accelerate market awareness, product evaluations, and adoption of xchange™, providing anesthesia providers with a practical, noninvasive approach to delivering positive airway pressure while supporting spontaneous ventilation. The collaboration between Pneuma Therapeutics and MED Alliance marks a significant step in advancing airway management solutions and improving patient outcomes in perioperative settings.